Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information

Chemical Biology & Drug Design
Lu TanJürgen Bajorath

Abstract

Ligand- and target structure-based methods are widely used in virtual screening, but there is currently no methodology available that fully integrates these different approaches. Herein, we provide an overview of various attempts that have been made to combine ligand- and structure-based computational screening methods. We then review different types of approaches that utilize protein-ligand interaction information for database screening and filtering. Interaction-based approaches make use of a variety of methodological concepts including pharmacophore modeling and direct or indirect encoding of protein-ligand interactions in fingerprint formats. These interaction-based methods have been successfully applied to tackle different tasks related to virtual screening including postprocessing of docking poses, prioritization of binding modes, selectivity analysis, or similarity searching. Furthermore, we discuss the recently developed interacting fragment approach that indirectly incorporates 3D interaction information into 2D similarity searching and bridges between ligand- and structure-based methods.

References

Feb 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·S M Syrjänen
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jun 21, 2001·Journal of Chemical Information and Computer Sciences·L XueJ Bajorath
Nov 5, 2002·Nature Reviews. Drug Discovery·Jürgen Bajorath
Nov 26, 2002·Journal of Chemical Information and Computer Sciences·Joseph L DurantJames G Nourse
May 28, 2003·Journal of Chemical Information and Computer Sciences·John D HollidayPeter Willett
Jul 23, 2003·Journal of Chemical Information and Computer Sciences·Ling XueJürgen Bajorath
May 25, 2004·Journal of Chemical Information and Computer Sciences·Romano T KroemerPieter F W Stouten
Aug 4, 2004·Current Opinion in Chemical Biology·Tudor I Oprea, Hans Matter
Nov 3, 2004·Nature Reviews. Drug Discovery·Douglas B KitchenJürgen Bajorath
Nov 24, 2004·Journal of Chemical Information and Computer Sciences·Matthew D Kelly, Ricardo L Mancera
Dec 17, 2004·Nature·Brian K Shoichet
Jan 7, 2005·Journal of Medicinal Chemistry·Claudio ChuaquiJuswinder Singh
Jan 26, 2005·Journal of Chemical Information and Modeling·Gerhard Wolber, Thierry Langer
Apr 28, 2005·Current Pharmaceutical Design·Florence L Stahura, Jürgen Bajorath
Jan 20, 2006·Journal of Medicinal Chemistry·Zhan DengJuswinder Singh
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ting-Wan LinShiou-Chuan Tsai
Mar 28, 2006·Journal of Chemical Information and Modeling·Chidochangu P MpamhangaPeter Willett
Mar 28, 2006·Journal of Chemical Information and Modeling·David VidalMiquel Pons
May 23, 2006·Amino Acids·D-Q WeiK-C Chou
Jun 24, 2006·Drug Discovery Today·Gerhard Klebe
Nov 30, 2006·Drug Discovery Today·Peter Willett
Jan 24, 2007·Journal of Chemical Information and Modeling·Gilles Marcou, Didier Rognan
Mar 3, 2007·Drug Discovery Today·Hanna Eckert, Jürgen Bajorath
Oct 24, 2007·Journal of Chemical Information and Modeling·Gabriela BarreiroWilliam L Jorgensen
Jan 16, 2008·Journal of Medicinal Chemistry·Irina G TikhonovaMarvin C Gershengorn
May 2, 2008·Journal of Medicinal Chemistry·Jennifer VenhorstChris G Kruse
Sep 30, 2008·Journal of Chemical Information and Modeling·Thomas J CrismanJürgen Bajorath
Nov 15, 2008·Journal of Chemical Information and Modeling·Lu TanJürgen Bajorath
Apr 15, 2009·Journal of Chemical Information and Modeling·Violeta I Pérez-NuenoJordi Teixidó
May 13, 2009·Journal of Chemical Information and Modeling·Jenny ChenJohn Bradshaw
Jun 13, 2009·Chemical Biology & Drug Design·Lu Tan, Jürgen Bajorath
Oct 2, 2009·Chemical Biology & Drug Design·Lu TanJürgen Bajorath
Dec 25, 2009·Journal of Chemical Information and Modeling·José BatistaJürgen Bajorath
Dec 30, 2009·Journal of Chemical Information and Modeling·Tomohiro SatoShigeyuki Yokoyama
Mar 17, 2010·Combinatorial Chemistry & High Throughput Screening·Yuan Wang, Jürgen Bajorath

❮ Previous
Next ❯

Citations

Jun 14, 2014·Progress in Biophysics and Molecular Biology·Sebastian SalentinMichael Schroeder
Jan 31, 2012·Chemistry & Biology·Olivier TaboureauBruno O Villoutreix
Aug 19, 2018·The Biochemical Journal·Blanca E Ruiz-MedinaRobert A Kirken
May 8, 2019·International Wound Journal·Ayelet LevyAmit Gefen
Jun 1, 2018·Current Medicinal Chemistry·Berin Karaman, Wolfgang Sippl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.